How to manage CVD risk in PCa patients during COVID-19
| Organiser | European School of Urology |
|---|---|
| CME | 1 |
| Duration | Approx. 60 – 90 minutes |
Moderator: PA Abrahamsson (SE)
Impact of COVID-19 on cardio-oncology
By Prof. dr. Arjun Ghosh (GB), cardio-oncologist
COVID-19 Recommendations for Prostate Cancer treatment by the EAU Guidelines
By Prof. dr. dr. Maria Ribal (ES), urologist
How to manage prostate cancer in a pandemic
By Dr. Ricardo Rendon (CA), urologic oncologist
Hormonal treatment of urological cancers during COVID-19
By Prof. Mark Linch (GB), oncologist
This online curriculum is developed by the Canadian Urological Association (CUA), the International Cardio-Oncology Society (ICOS), and the European Association of Urology (EAU) and combines quality scientific content with current evidence-based recommendations and real-life clinical practice experience.